GERMANTOWN, Md., Dec. 31, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON) today announced the passing of Larry D. Horner, a director of the Company. Mr. Horner joined the Board of Directors in 2008 and played an invaluable part in guiding the Company throughout his tenure on the Board.
“It is with profound sadness that we announce the passing of our colleague, Larry Horner,” stated Randal J. Kirk, Intrexon’s Chairman and Chief Executive Officer. “Larry was an excellent board member as well as a mentor to me over the last twenty years having served on the boards of New River Pharmaceuticals, Clinical Data and Intrexon. He was a great human being with impeccable judgement and respected and loved by many. On behalf of the Board and Intrexon employees, our deepest sympathies go to all of Larry’s family and friends. We shall miss him greatly.”
As CEO of Peat Marwick Mitchell & Co., Mr. Horner engineered the firm’s merger with Klvynverd Main Goerdler, forming KPMG Peat Marwick, and served as the combined company’s CEO. Subsequent to his retirement from KPMG, Mr. Horner served as Chairman of several private and public companies involved in finance, real estate and manufacturing. His broad service on corporate boards included those of Clinical Data, Inc., ConocoPhillips, UTStarcom, Inc., New River Pharmaceuticals, Inc., Wire & Cable Specialties Corp., and Atlantis Plastics, Inc.
About Intrexon Corporation
Intrexon Corporation (NYSE: XON) is Powering the Bioindustrial Revolution with Better DNA to create biologically-based products that improve the quality of life and the health of the planet. The Company’s integrated technology suite provides its partners across diverse markets with industrial-scale design and development of complex biological systems delivering unprecedented control, quality, function, and performance of living cells. We call our synthetic biology approach Better DNA®, and we invite you to discover more at www.dna.com.
Trademarks
Intrexon, Powering the Bioindustrial Revolution with Better DNA, and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
For more information regarding Intrexon Corporation, contact:
Investor Contact:
Christopher Basta
Vice President, Investor Relations
Tel: +1 (561) 410-7052
investors@intrexon.com
Corporate Contact:
Marie Rossi, Ph.D.
Senior Manager, Technical Communications
Tel: +1 (301) 556-9850
publicrelations@intrexon.com
Logo - http://photos.prnewswire.com/prnh/20130919/NY83283LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/intrexon-mourns-the-passing-of-larry-horner-a-board-member-300198314.html
SOURCE Intrexon Corporation
